6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: NeuroSense Therapeutics Ltd.
Filed: March 11, 2026
Period of Report: March 11, 2026
Accession Number: 0001213900-26-025952

View Document ↗ View on SEC.gov ↗